UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Thrombosis and haemostasis, 2017, Vol.117 (2), p.219-230

2017

Volltextzugriff (PDF)

Biomarkers for prediction of venous thromboembolism in cancer

Blood, 2013-09, Vol.122 (12), p.2011-2018

2013

Volltextzugriff (PDF)

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Blood, 2021-03, Vol.137 (12), p.1669-1678

2021

Volltextzugriff (PDF)

Biomarkers and venous thromboembolism

Arteriosclerosis, thrombosis, and vascular biology, 2009-03, Vol.29 (3), p.332-336

2009

Volltextzugriff (PDF)

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2016-10, Vol.17 (10), p.e452-e466

2016

Volltextzugriff (PDF)

Cancer-associated venous thromboembolism

Nature reviews. Disease primers, 2022-02, Vol.8 (1), p.11-11, Article 11

2022

Volltextzugriff (PDF)

Prediction of venous thromboembolism in cancer patients

Blood, 2010-12, Vol.116 (24), p.5377-5382

2010

Volltextzugriff (PDF)

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Blood, 2017-03, Vol.129 (13), p.1831-1839

2017

Volltextzugriff (PDF)

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy

Chest, 2008-06, Vol.133 (6), p.844S-886S

2008

Volltextzugriff (PDF)

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

Scientific reports, 2021-06, Vol.11 (1), p.12967-12967, Article 12967

2021

Volltextzugriff (PDF)

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Scientific reports, 2021-02, Vol.11 (1), p.3092-3092, Article 3092

2021

Volltextzugriff (PDF)

Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer

Haematologica (Roma), 2018-09, Vol.103 (9), p.1549-1556

2018

Volltextzugriff (PDF)

High D-dimer levels are associated with poor prognosis in cancer patients

Haematologica (Roma), 2012-08, Vol.97 (8), p.1158-1164

2012

Volltextzugriff (PDF)

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2099-2103

2011

Volltextzugriff (PDF)

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

Nature genetics, 2009-04, Vol.41 (4), p.450-454

2009

Volltextzugriff (PDF)

A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient

Orphanet journal of rare diseases, 2024-05, Vol.19 (1), p.193-193, Article 193

2024

Volltextzugriff (PDF)

Plasma Clot Properties in Patients with Pancreatic Cancer

Cancers, 2023-08, Vol.15 (16), p.4030

2023

Volltextzugriff (PDF)

The role of podoplanin in cancer-associated thrombosis

Thrombosis research, 2018-04, Vol.164, p.S34-S39

2018

Volltextzugriff (PDF)

Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer

Haematologica (Roma), 2024-04, Vol.109 (4), p.1128

2024

Volltextzugriff (PDF)

Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI

Oncology research and treatment, 2018-01, Vol.41 (Suppl 5), p.1-30

2018

Volltextzugriff (PDF)

Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitals

Scientific reports, 2024-07, Vol.14 (1), p.17737-8, Article 17737

2024

Volltextzugriff (PDF)

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4124-4129

2009

Volltextzugriff (PDF)

Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3870-3875

2012

Volltextzugriff (PDF)

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Annals of hematology, 2020-12, Vol.99 (12), p.2763-2771

2020

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Aktive Filter

KollektionWiley HSS Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(331)

Publikationsform

Artikel
(416)
Buchkapitel
(2)
Berichte
(1)
Texte
(1)

Sprache

Englisch
(392)
Japanisch
(45)
Deutsch
(39)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Biomarkers for prediction of venous thromboembolism in cancer

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Biomarkers and venous thromboembolism

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

Cancer-associated venous thromboembolism

Prediction of venous thromboembolism in cancer patients

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients

Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer

High D-dimer levels are associated with poor prognosis in cancer patients

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient

Plasma Clot Properties in Patients with Pancreatic Cancer

The role of podoplanin in cancer-associated thrombosis

Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer

Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI

Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitals

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Tumor Grade Is Associated With Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting

Aktive Filter

Suchergebnisse filtern